GlycoMimetics Inc (GLYC) Options

inching up here.

looks interesting.

2m short to cover(not including today)

ZERO BORROW/15% fee(no rebate now so bear trap could snap now

Worth 10Xs now,add in 200m paid acquisition,$3+no matter how it’s sliced,so should go quick to $1

https://ih.advfn.com/stock-market/NASDAQ/glycomimetics-GLYC/stock-news/95440364/form-425-prospectuses-and-communications-busine

Zero borrow,acq.,death hr over now,could pop 100%-200% like last time

GLYC................................https://stockcharts.com/h-sc/ui?s=GLYC&p=W&b=5&g=0&id=p86431144783

GOOD CALL

GLYC BELL BUY INTO VOLUME AND BIG GAPPER

GLYC (Circa 55-Mil. Flt., 2%): $0.29, 45%; (no news) "carbohydrates" approach to Cancer, immune, etc., diseases (Maryland).

See ya-all TUESDAY!! (Happy 'All Presidents Day'!!! Used to be just Washington's birthday. (His 'monument' is a circa 700-foot-tall OBELISK --- where the fluck were his ANCESTORS from, ancient EGYPT???)

GLYC.........................................a/h

GLYC BELL BUY INTO VOLUME AND BIG GAPPER

Tomorrow November 19th, GLYC will be presenting thier developments at the London Healthcare conference. Hopefully this results into this stock shooting up. 🚀🚀

Looks interesting

Looks interesting

GLYC Sold at .60 yesterday for 203% profit.

Next micro cap buyout or hostile take over will be BFRI interesting price action after hours FDA approved drug for AK skin cancer with late stage pipeline for Basil Cell and Squamous cell carcinoma Phase 3 and Acne Phase 2 call your dermatologist I bet they use Ameluz
the FDA also just green lighted 3 tubes can be used in a single session from 1 $400 a tube =$1200

https://www.biofrontera-us.com/research/product-pipeline

https://www.investing.com/news/company-news/biofrontera-locks-phase-3-sbcc-study-database-for-analysis-93CH-3662035


https://us.ameluz.com/
$GLYC

Bought some more GLYC this morning.

================

Biotech Up Over +100% Premarket Following Merger And Funding Announcement

Tuesday, October 29, 2024

A Maryland-based biotech company is already dominating Tuesday’s session prior to the opening bell after it was announced that the company will be merging with Crescent Biopharma and that it secured approximately $200 million in funding to financing operations through 2027, according to this morning’s release.

Traders were quick to snatch up shares of GlycoMimetics Inc. (Nasdaq:GLYC), with the current bid sitting at $0.3694/share (+119.62% implied open for sellers) at the time of writing. It should be an exciting session for this micro cap!

GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it plays in inflammation, cancer, and infection.

https://www.allpennystocks.com/specialreportsus/3692/biotech-up-over-100-premarket-following-merger-and-funding-announcement?utm_source=advfn

$GLYC

Renewed Opportunities!

My tons of GLYC shares at $0.17 now have Huge gains!!! Go, go, go!!!!!

Higher Peaks!

There is a lot of room.
Let's do it!

Up 200% 09:44 AM EDT, 10/29/2024 (MT Newswires) -- GlycoMimetics' (GLYC) shares climbed by more than 125% early Tuesday after saying it has agreed to be acquired by Crescent Biopharma, a privately held biotechnology company advancing a pipeline of oncology therapeutics.

glyc....................................https://stockcharts.com/h-sc/ui?s=glyc&p=W&b=5&g=0&id=p86431144783

Bankruptcy proceedings next. You been warned. Check out my latest post.

GLYC was $3.5 in Jan. Institutions and mutual funds holding 50 million shares at dollars, out of 64 million OS.

GLYC, Chief Medical Officer bought 310,000 shares at $0.26 at open market on June 21. He must know something.


https://www.otcmarkets.com/filing/html?id=17638385&guid=RXO-kWK48IECJth

GLYC: Article here ---
https://www.defenseworld.net/2024/06/25/glycomimetics-inc-nasdaqglyc-insider-edwin-rock-buys-190000-shares.html#google_vignette

you usually post the bottom charts before they go

Hitting .43s looking good

Delisting letter coming. You have been warned.

GLYC............................https://stockcharts.com/h-sc/ui?s=GLYC&p=W&b=5&g=0&id=p86431144783

Nice insider buys here = https://www.otcmarkets.com/filing/html?id=17638385&guid=NwO-kFXCNX90B3h

GLYC new low

Well? Good thing i held off on taking a position….

Gotta wait it out

Hopefully the FDA will give GLYC the the green light after reviewing phase 3 data in June

GLYC under $2

GLYC under $4

Dilution.

Reversal

Picked up a few heavy racks of shares under 2.95 today.


$GLYC

GLYC: Hey!!!! WHAT???? (HA-HA!!)

$GLYC: The chart is screaming bullflag breakout on 100day chart

Now at 2.50


Perfect BULL FLAG.


NICE


GO $GLYC

$GLYC Crazy runner here..on watch to see if it continues as insider bought a ton of shares..

https://stocktwits.com/soll/message/497100283

https://stockcharts.com/c-sc/sc?s=GLYC&p=D&b=5&g=0&i=0&r=1668953354914

THANKS!

yup and congrats on your other runner.

GO-GO-GO-GLYC!!!

PS: Hey, Girl, tap my latest POSTS behind @GRND --- what a SPECTACLE that one is!!!! (I grabbed their WARRANTS!!)

looking good here.

wow, new highs hitting right now!

and back to 2 bucks. lets see what tomorrow brings.